Defensins purified from human granulocytes bind c1q and activate the classical complement pathway like the transmembrane glycoprotein gp41 of HIV- 1

Molecular Immunology

Volumn 34, Issue 11, 1997, Pages 809-816

  Prohászka, Zoltán ^a   Német, Katalin ^a,b   Csermely, Péter ^c   Hudecz, Ferenc ^d   Mezõ, Gábor ^d   Füst, George ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b National Institute of Haematology and Immunology Budapest   (Hungary)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^d EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

Clq binding; Complement activation; Defensins; gp41

Indexed keywords

COMPLEMENT COMPONENT C1Q; DEFENSIN; GLYCOPROTEIN GP 41; MEMBRANE PROTEIN; SYNTHETIC PEPTIDE;

ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; GRANULOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VIRUS INACTIVATION;

ANTI-INFECTIVE AGENTS; ANTIGEN-ANTIBODY REACTIONS; BLOOD PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMPLEMENT C1Q; COMPLEMENT C4B; COMPLEMENT PATHWAY, CLASSICAL; DEFENSINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRANULOCYTES; HIV ENVELOPE PROTEIN GP41; HUMANS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0344222176     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(97)00097-7     Document Type: Article

References (34)

1. Absolom, D. R. (1986) Basic methods for the study of phagocytosis. In Methods in Enzymology (Edited by DiSabato G. and Everse J.), Vol. 132, pp. 151-152. Academic Press.
2. Arlaud G. J., Sim R. B., Duplaa A. M. and Colomb M. G. (1979) Differential elution of Clq, Clr and Cls from human Cl bound to immune aggregates. Use in the rapid purification of Cl subcomponents. Molec. Immun. 16, 445-448.
3. Bartholomew R. M., Esser A. F., Müller-Eberhard H. J. (1978) Lysis of oncornaviruses by human serum. J. exp. Med. 147, 844-853.
4. Bateman A., Singh A., Shistik C., Mars W. M. and Solomon S. (1991) The isolation and identification of multiple forms of the neutrophil granule peptides from human leukemic cells. J. biol. Chem. 266, 7524-7530
5. Bogdán K., Vordermeier H. M., Jurcevic S., Ivanyi J. and Hudecz, F. (1997) Analysis of the antigenic structure of two immunodominant region of the 16kDa protein of M. tuberculosis: elucidation of the minimal size of T-cell epitopes. In Innovation and Perspectives in Solid-phase Synthesis - Peptides, Polypeptides and Oligonucleotides (Edited by Epton R.). Mayflower World Wide, Birmingham, U.K. In press.
6. Charp P. A., Rice W. G., Raynor R. L., Reimund E., Kinkade J. M. Jr., Ganz T., Selsted M. E., Lehrer R. I. and Kuo J. R. (1988) Inhibition of protein kinase C by defensins, antibiotic peptides from human neutrophils. Biochem. Pharmacol. 37, 951-956.
7. Daher K. A., Selsted M. E. and Lehrer R. I. (1986) Direct inactivation of viruses by human granulocyte defensins. J. Virol. 60, 1068-1074.
8. Denner J., Norley S. and Kurth R. (1994) The immuno-suppressive peptide of HIV-1: functional domains and immune response in AIDS patients. AIDS 8, 1063-1072.
9. Dierich M. P., Ebenbichler C. F., Marschang P., Füst G., Thielens N. M. and Arlaud G. J. (1993) HIV and human complement: mechanisms of interaction and biological implication. Immun. Today 14, 435-440.
10. Duncan A. R. and Winter G. (1988) The binding site for Clq on IgG. Nature 332, 738-740.
11. Ebenbichler C. F., Thielens N. M., Vornhagen R., Marschang P., Arlaud G. J. and Dierich M. P. (1991) Human immuno-deficiency virus type-1 activates the classical pathway of complement by direct Cl binding through specific sites in the transmembrane glycoprotein gp41. J. exp. Med. 174, 1417-1424.
12. Fleischmann J., Selsted M. E. and Lehrer R. I. (1985) Opsonic activity of MCP-1 and MCP-2, cationic peptides from rabbit alveolar macrophages. Diag. Microbiol. Infect. Dis. 3, 951-956.
13. Füst G., Medgyesi G. A., Rajnavölgyi É., Csécsi-Nagy M., Czikora K. and Gergely J. (1978) Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of Cl. Immunology 35, 873-884.
14. Füst G., Prohászka Z., Hidvégi T., Thielens N. M., Arlaud G., Tóth F. D., Kiss J., Dierich M. P. and Ujhelyi E. (1994) Competition of complement proteins and specific antibodies for binding to HIV-1 envelope antigens. Acta Microbiol. Immun. Hung. 41, 27-31.
15. Ganz T. and Lehrer R. I. (1994) Defensins. Curr. Opin. Immun. 6, 584-589.
16. Ganz T., Selsted M. E., Szklarek D., Harwig S. S. L., Daher K., Bainton D. F. and Lehrer R. I. (1985) Defensins. Natural peptide antibiotics of human neutrophils. J. clin. Invest. 76, 1427-1435.
17. Ganz T., Selsted M. E. and Lehrer R. I. (1990) Defensins. Eur. J. Haemat. 44, 1-8.
18. Gnann J. W. Jr., Nelson J. A. and Oldstone B. A. (1987) Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus. J. Virol. 61, 2639-2641.
19. Hidvégi T., Prohászka Z., Ujhelyi E., Thielens N. M., Dierich M. P., Hampl H., Arlaud G., Nagy K. and Füst G. (1993) Studies on the mechanism of complement-mediated inhibition of antibody binding to HIV gp41. Clin. exp. Immun. 94, 490-493.
20. Hill C. P., Yee J., Selsted M. E. and Eisenberg D. (1991) Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science 251, 1481-1485.
21. Laemmli U. K. (1970) Clavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227, 680-685.
22. Lehrer R. I. (1993) Defensins: antimicrobial and cytotoxic peptides of mammalian cells. A. Rev. Immun. 11, 105-128.
23. Lichtenstein A. K., Ganz T., Nguyen T. M., Selsted M. E. and Lehrer R. I. (1988) Mechanism of target cytolysis by peptide defensins. J. Immun. 140, 2686-2694.
24. Mitchell W. M., Torres J., Johnson P. R., Hirsch V., Yilma T., Gardner M. B., Robinson W. E. Jr. (1995) Antibodies to the putative SIV infection-enhancing domain diminish beneficial effects of an SIV gp160 vaccine in rhesus macaques. AIDS 9, 27-34.
25. Monell C. R. and Strand M. (1994) Structural and functional similarities between synthetic HIV gp41 peptides and defensins. Clin. Immun. Immunopath. 71, 315-324.
26. Okrent D. G., Lichtenstein A. K. and Ganz T. (1990) Direct cytotoxicity of polymorphonuclear leukocyte granule proteins to human lung-derived cells and endothelial cells. Am. Rev. Respir. Dis. 141, 179-185.
27. Panyutich A. V., Szold O., Hoon P. H. and Tseng Y., Ganz T. (1994) Identification of defensin binding to Cl complement. FEBS Lett. 356, 169-173.
28. Prohászka Z., Hidvégi T., Ujhelyi E., Stoiber H., Dierich M. P., Süsal C. and Füst G. (1995) Interaction of complement and specific antibodies with the external glycoprotein 120 of HIV-1. Immunology 85, 184-189.
29. Ratner L., Haseltine W., Patarca R., Livak K. J., Starcich B., Josephs S. F., Doran E. R., Rafalski J. A., Whitehorn E. A., Baumeister K., Ivanoff L., Petteway S. R., Pearson M. L., Lautenberger J. A., Papas T. S., Ghrayeb J., Chang N., Gallo R. C. and Wong-Staal F. (1985) Complete nucleotide sequence of the AIDS-virus, HTLV-III. Nature 313, 277.
30. 2+ influx in Jurkat T Cells by a synthetic peptide with sequence identity to HIV-1 gp41. J. Immun. 144, 3928-3935.
31. Ruegg C. L., Monell C. R. and Strand M. (1989) Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type I. J. Virol. 63, 3257-3260.
32. Thielens N. M., Bally I. M., Ebenbichler C. F., Dierich M. P. and Arlaud G. J. (1993) Further characterization of the interaction between the Clq subcomponent of human Cl and the transmembrane envelope glycoprotein gp41 of HIV-1. J. Immun. 151, 6583-6592.
33. Welsh R. M., Cooper N. R., Jensen F. C. and Oldstone M. B. A. (1975) Human serum lyses RNA tumor viruses. Nature 257, 612-614.
34. White S. H., Wimley C. W. and Sested M. E. (1995) Structure, function, and membrane integration of defensins. Curr. Opin. Struct. Biol. 5, 521-527.